financetom
Business
financetom
/
Business
/
Aon Q3 revenue up 7% to $4.0 bln, beats estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Aon Q3 revenue up 7% to $4.0 bln, beats estimates
Oct 31, 2025 3:49 AM

Overview

* Aon Q3 revenue grows 7% to $4.0 bln, beating analyst expectations

* Adjusted EPS for Q3 increases 12%, surpassing analyst estimates

* Company reports 7% organic revenue growth, driven by Aon United strategy

Outlook

* Aon remains confident in achieving full-year 2025 financial targets

* Company expects sustainable growth in 2026 and beyond

Result Drivers

* AON UNITED STRATEGY - Co attributes 7% organic revenue growth to Aon United strategy, focusing on talent acquisition and data analytics scaling

* RISK CAPITAL GROWTH - 7% increase in Risk Capital revenue driven by new business and strong retention in North America and EMEA

* HUMAN CAPITAL GROWTH - 8% increase in Human Capital revenue due to strength in talent analytics and core health and benefits

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $3.99 $3.95

Revenue bln bln (14

Analysts

)

Q3 Beat $3.05 $2.91

Adjusted (18

EPS Analysts

)

Q3 EPS $2.11

Q3 7%

ORGANIC

GROWTH

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy", 7 "hold" and 2 "sell" or "strong sell"

* The average consensus recommendation for the multiline insurance & brokers peer group is "buy"

* Wall Street's median 12-month price target for Aon PLC ( AON ) is $420.00, about 21.9% above its October 30 closing price of $328.19

* The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 20 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Immuno-Oncology Focused ALX Oncology Stock Falls On Updated Data From Mid-Stage Evorpacept Combo Study In Gastric Cancer Patients
Immuno-Oncology Focused ALX Oncology Stock Falls On Updated Data From Mid-Stage Evorpacept Combo Study In Gastric Cancer Patients
Aug 1, 2024
On Wednesday, ALX Oncology Holdings Inc ( ALXO ). released topline data from its Phase 2 ASPEN-06 clinical trial. ASPEN-06 is evaluating evorpacept in combination with trastuzumab, Cyramza (ramucirumab), and paclitaxel (collectively, TRP) against TRP alone for HER2-positive gastric/GEJ cancer, where all patients had received an anti-HER2 agent in prior lines of therapy. The ASPEN-06 study is testing a new...
Ionis Pharmaceuticals' Q2 loss Narrows as Revenue Increases
Ionis Pharmaceuticals' Q2 loss Narrows as Revenue Increases
Aug 1, 2024
09:06 AM EDT, 08/01/2024 (MT Newswires) -- Ionis Pharmaceuticals ( IONS ) reported a Q2 loss Thursday of $0.45 per diluted share, narrowing from a loss of $0.60 a year earlier. Analysts polled by Capital IQ expected a loss of $0.91. Revenue for the quarter ended June 30 was $225 million, up from $188 million a year earlier. Analysts surveyed...
Kellanova raises 2024 forecasts on stable snacks demand in North America
Kellanova raises 2024 forecasts on stable snacks demand in North America
Aug 1, 2024
(Reuters) - Kellanova ( K ) raised its annual organic sales and profit forecasts on Thursday as consumers opted for its breakfast cereals and ready-to-eat snacks such as Pringles despite higher prices. Shares of the company were up 4% before the bell, after it also beat Wall Street expectations for second-quarter results. The company, which previously made up Kellogg's (...
EU seeking feedback on draft antitrust guidelines on exclusionary abuses
EU seeking feedback on draft antitrust guidelines on exclusionary abuses
Aug 1, 2024
BRUSSELS (Reuters) - The European Commission said on Thursday it had launched a public consultation inviting all interested parties to comment on draft guidelines on exclusionary abuses of dominance, which include predatory pricing, margin squeeze, exclusive dealing and refusal to supply. In a statement, the Commission said those guidelines will help increase legal certainty to the benefit of consumers, and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved